Medicare Advantage Has a Coverage Gap That Could Hurt Your Health

A December 2025 study in The American Journal of Managed Care found potential care gaps in Medicare Advantage, especially for mental health services. Researchers saw increased mental health visits after beneficiaries switched back to traditional Medicare, consistent with narrower MA provider networks and limited behavioral health access. The piece is consumer-focused and unlikely to move markets broadly, but it reinforces headwinds for Medicare Advantage plan quality perceptions.

Analysis

The investable read-through is not to healthcare insurers broadly but to the utilization mix embedded in Medicare Advantage economics. If mental-health access is structurally poorer than original Medicare, MA plans have been underpricing a high-friction, low-visibility benefit category; that eventually shows up in higher churn, lower star ratings, and potentially higher medical-cost volatility as untreated behavioral health spills into ER and primary care. The second-order beneficiary is not necessarily the large MA incumbents, but outpatient behavioral-health capacity, tele-mental-health platforms, and provider enablement firms that can capture displaced demand without requiring narrow-network gatekeeping.

For public equities, the most important implication is that this is a slow-burn regulatory overhang, not an immediate claims shock. The catalyst path is months to years: OIG scrutiny, plan design changes, and potential CMS network-access enforcement, with the near-term effect being reputational rather than earnings. The risk is asymmetry in any insurer valuation multiple that depends on MA growth and retention, because even a modest increase in disenrollment or supplemental benefit costs can compress valuation before it materially hits EPS.

The contrarian angle is that the market may be underestimating how much utilization is being suppressed rather than eliminated. If patients are forced out of MA networks, demand does not disappear — it migrates to traditional Medicare, emergency settings, or self-pay behavior, which can actually improve economics for providers with broad access and worsen them for narrow-network plans. That makes this a relative-value rather than outright sector-short setup: the likely winners are access-rich care delivery names, while the losers are plans with the weakest behavioral-health network depth and the least credible directory accuracy.

Key Decisions for Investors

• Favor long UNH / short a basket of smaller MA-centric managed-care names for a 3-6 month relative-value trade; thesis is that breadth of network and pricing power will matter more as behavioral-health scrutiny rises.
• Initiate a long position in AMN or DOCS only on pullbacks, targeting 6-12 months; these names can benefit if displaced mental-health demand shifts toward scalable, lower-friction access models.
• Avoid adding to pure MA-growth exposure until next CMS or OIG commentary; use any rally in MA-heavy insurers to trim 25-35% of tactical exposure over the next 1-2 quarters.
• If you want an options expression, buy 6-9 month put spreads on a high-MA-penetration insurer versus current levels; the trade is designed for multiple compression, not an immediate earnings miss.
• Watch for a regulatory catalyst: any CMS enforcement on provider directory accuracy or behavioral-health adequacy would be the point to rotate more aggressively into providers and away from MA.